Herbert Y Meltzer

  • 69952 Citations
1961 …2022

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article
Review article

ACNP task force report on SSRIs and suicidal behavior in youth

Mann, J. J., Emslie, G., Baldessarini, R. J., Beardslee, W., Fawcett, J. A., Goodwin, F. K., Leon, A. C., Meltzer, H. Y., Ryan, N. D., Shaffer, D. & Wagner, K. D., Mar 1 2006, In : Neuropsychopharmacology. 31, 3, p. 473-492 20 p.

Research output: Contribution to journalReview article

114 Scopus citations

Adverse effects of the atypical antipsychotics

Meltzer, H. Y., Oct 5 1998, In : Journal of Clinical Psychiatry. 59, SUPPL. 12, p. 17-22 6 p.

Research output: Contribution to journalReview article

103 Scopus citations

Adverse events related to olanzapine

Conley, R. R. & Meltzer, H. Y., May 22 2000, In : Journal of Clinical Psychiatry. 61, SUPPL. 8, p. 26-30 5 p.

Research output: Contribution to journalReview article

70 Scopus citations

A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia

Woodward, N. D., Purdon, S. E., Meltzer, H. Y. & Zald, D. H., Sep 1 2005, In : International Journal of Neuropsychopharmacology. 8, 3, p. 457-472 16 p.

Research output: Contribution to journalReview article

449 Scopus citations

Antipsychotic drugs: Comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection

Lieberman, J. A., Bymaster, F. P., Meltzer, H. Y., Deutch, A. Y., Duncan, G. E., Marx, C. E., Aprille, J. R., Dwyer, D. S., Li, X. M., Mahadik, S. P., Duman, R. S., Porter, J. H., Modica-Napolitano, J. S., Newton, S. S. & Csernansky, J. G., Sep 1 2008, In : Pharmacological Reviews. 60, 3, p. 358-403 46 p.

Research output: Contribution to journalReview article

168 Scopus citations

Antipsychotic drugs in bipolar disorder

Ertugrul, A. & Meltzer, H. Y., Sep 1 2003, In : International Journal of Neuropsychopharmacology. 6, 3, p. 277-284 8 p.

Research output: Contribution to journalReview article

31 Scopus citations

Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment.

Meltzer, H. Y., Davidson, M., Glassman, A. H. & Vieweg, W. V. R., Jan 1 2002, In : The Journal of clinical psychiatry. 63 Suppl 9, p. 25-29 5 p.

Research output: Contribution to journalReview article

45 Scopus citations

Assessing the effects of atypical antipsychotics on negative symptoms

Meltzer, H. Y., Oct 5 1998, In : Journal of Clinical Psychiatry. 59, SUPPL. 12, p. 28-34 7 p.

Research output: Contribution to journalReview article

41 Scopus citations

Assessment of EPS and tardive dyskinesia in clinical trials

Meltzer, H. Y., Oct 5 1998, In : Journal of Clinical Psychiatry. 59, SUPPL. 12, p. 23-27 5 p.

Research output: Contribution to journalReview article

36 Scopus citations

Association between the -2548G/A polymorphism of the leptin gene and antipsychotic-induced weight gain: Analysis of the CATIE sample and meta-analysis

Yoshida, K., Maciukiewicz, M., Zai, C. C., Gonçalves, V. F., Brandl, E. J., Lieberman, J. A., Meltzer, H. Y., Tiwari, A. K., Kennedy, J. L. & Müller, D. J., Aug 30 2020, In : Progress in Neuro-Psychopharmacology and Biological Psychiatry. 102, 109952.

Research output: Contribution to journalReview article

Attention must be paid: The association of plasma clozapine/NDMC ratio With working memory

Meltzer, H. Y., Jun 1 2015, In : American Journal of Psychiatry. 172, 6, p. 502-504 3 p.

Research output: Contribution to journalReview article

7 Scopus citations

Attention must be paid: The association of plasma clozapine/NDMC ratio With working memory

Meltzer, H. Y., Jun 2015, In : American Journal of Psychiatry. 172, 6, p. 502-504 3 p.

Research output: Contribution to journalReview article

9 Scopus citations

Atypical antipsychotics for treatment of depression in schizophrenia and affective disorders

Meltzer, H. Y., Oct 5 1998, In : Journal of Clinical Psychiatry. 59, SUPPL. 12, p. 41-45 5 p.

Research output: Contribution to journalReview article

51 Scopus citations

Augmentation of antipsychotic drug action by azapirone 5-HT1A receptor partial agonists: A meta-analysis

Kishi, T., Meltzer, H. Y. & Iwata, N., Jul 1 2013, In : International Journal of Neuropsychopharmacology. 16, 6, p. 1259-1266 8 p.

Research output: Contribution to journalReview article

21 Scopus citations

Azapirone 5-HT1A receptor partial agonist treatment for major depressive disorder: Systematic review and meta-analysis

Kishi, T., Meltzer, H. Y., Matsuda, Y. & Iwata, N., Jan 1 2014, In : Psychological Medicine. 44, 11, p. 2255-2269 15 p.

Research output: Contribution to journalReview article

12 Scopus citations

Biochemical studies in schizophrenia

Meltzer, H. Y., Jan 1 1976, In : Schizophrenia bulletin. 2, 1, p. 10-18 9 p.

Research output: Contribution to journalReview article

9 Scopus citations

Clinical development of atypical antipsychotics: Research design and evaluation

Meltzer, H. Y., Oct 5 1998, In : Journal of Clinical Psychiatry. 59, SUPPL. 12, p. 10-16 7 p.

Research output: Contribution to journalReview article

20 Scopus citations

Clozapine: Balancing safety with superior antipsychotic efficacy

Meltzer, H. Y., Oct 1 2012, In : Clinical Schizophrenia and Related Psychoses. 6, 3, p. 134-144 11 p.

Research output: Contribution to journalReview article

115 Scopus citations

Dexamethasone bioavailability: Implications for DST research

Lowy, M. T. & Meltzer, H. Y., Jan 1 1987, In : Biological psychiatry. 22, 3, p. 373-385 13 p.

Research output: Contribution to journalReview article

67 Scopus citations

Dimensions of outcome with clozapine

Meltzer, H. Y., Jan 1 1992, In : British Journal of Psychiatry. 160, MAY. SUPPL. 17, p. 46-53 8 p.

Research output: Contribution to journalReview article

226 Scopus citations

Diretrizes da Federação Mundial das Sociedades de Psiquiatria Biológica para o tratamento biológico da esquizofrenia parte 1: Tratamento agudo

Translated title of the contribution: World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia part 1: Acute treatmentFalkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Möller, H. J., Altamura, A. C., Andreasen, N., Barnes, T. R. E., Beckmann, H., Ciprian-Ollivier, J., Crow, T., David, A., Davidson, M., Deakin, B., Elkis, H., Farde, L., Gaebel, W., Gallhofer, B., Gerlach, J. & 17 others, Hirsch, S. R., Hojaij, C. R., Jablensky, A., Kane, J., Kojima, T., Von Knorring, L., McGorry, P., Meltzer, H., Moussaoui, D., Müller-Spahn, F., Olie, J. P., Palha, A. P., Sato, M., Sauer, H., Schooler, N., Weinberger, D. & Yamawaki, S., Dec 1 2006, In : Revista de Psiquiatria Clinica. 33, SUPPL. 1, p. 7-64 58 p.

Research output: Contribution to journalReview article

6 Scopus citations

Diretrizes da Federação Mundial das Sociedades de Psiquiatria Biológica para o tratamento biológico da esquizofrenia parte 2: Tratamento de longo prazo

Translated title of the contribution: World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia part 2: Long-term treatmentFalkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Möller, H. J., Altamura, A. C., Andreasen, N., Barnes, T. R. E., Beckmann, H., Ciprian-Ollivier, J., Crow, T., David, A., Davidson, M., Deakin, B., Elkis, H., Farde, L., Gaebel, W., Gallhofer, B., Gerlach, J. & 17 others, Hirsch, S. R., Hojaij, C. R., Jablensky, A., Kane, J., Kojima, T., Von Knorring, L., McGorry, P., Meltzer, H., Moussaoui, D., Müller-Spahn, F., Olie, J. P., Palha, A. P., Sato, M., Sauer, H., Schooler, N., Weinberger, D. & Yamawaki, S., Dec 1 2006, In : Revista de Psiquiatria Clinica. 33, SUPPL. 1, p. 65-100 36 p.

Research output: Contribution to journalReview article

4 Scopus citations

Does stimulation of 5-HT1A receptors improve cognition in schizophrenia?

Meltzer, H. Y. & Sumiyoshi, T., Dec 16 2008, In : Behavioural Brain Research. 195, 1, p. 98-102 5 p.

Research output: Contribution to journalReview article

124 Scopus citations

Dopaminergic and serotonergic control of neuroendocrine function.

Gudelsky, G. A., Simonovic, M. & Meltzer, H. Y., Jan 1 1984, In : Monographs in neural sciences. 10, p. 85-102 18 p.

Research output: Contribution to journalReview article

9 Scopus citations

Effect of benzamide drugs on prolactin secretion: relation to the dopamine receptor.

Meltzer, H. Y., So, R. & Fang, V. S., Dec 1 1982, In : Advances in biochemical psychopharmacology. 35, p. 61-82 22 p.

Research output: Contribution to journalReview article

4 Scopus citations

Effect of serotonin precursors and serotonin agonists on plasma hormone levels.

Meltzer, H. Y., Wiita, B., Tricou, B. J., Simonovic, M., Fang, V. & Manov, G., Jan 1 1982, In : Advances in biochemical psychopharmacology. 34, p. 117-139 23 p.

Research output: Contribution to journalReview article

65 Scopus citations

Evaluating the effects of antipsychotics on cognition in schizophrenia

Meltzer, H. Y., Oct 5 1998, In : Journal of Clinical Psychiatry. 59, SUPPL. 12, p. 35-40 6 p.

Research output: Contribution to journalReview article

33 Scopus citations

Factors affecting outcome in schizophrenia and their relevance for psychopharmacological treatment

Carlo Altamura, A., Bobo, W. V. & Meltzer, H. Y., Sep 1 2007, In : International Clinical Psychopharmacology. 22, 5, p. 249-267 19 p.

Research output: Contribution to journalReview article

48 Scopus citations

Genetic dissection of atypical antipsychotic-induced weight gain: Novel preliminary data on the pharmacogenetic puzzle

Basile, V. S., Masellis, M., McIntyre, R. S., Meltzer, H. Y., Lieberman, J. A. & Kennedy, J. L., Oct 22 2001, In : Journal of Clinical Psychiatry. 62, SUPPL. 23, p. 45-66 22 p.

Research output: Contribution to journalReview article

205 Scopus citations

Long-term effects of neuroleptic drugs on the neuroendocrine system.

Meltzer, H. Y., Jan 1 1985, In : Advances in biochemical psychopharmacology. 40, p. 59-68 10 p.

Research output: Contribution to journalReview article

35 Scopus citations

Lorcaserin and pimavanserin: Emerging selectivity of serotonin receptor subtype-targeted drugs

Meltzer, H. Y. & Roth, B. L., Dec 2 2013, In : Journal of Clinical Investigation. 123, 12, p. 4986-4991 6 p.

Research output: Contribution to journalReview article

58 Scopus citations

Measuring outcome in schizophrenia: Differences among the atypical antipsychotics

Meltzer, H. Y., Oct 5 1998, In : Journal of Clinical Psychiatry. 59, SUPPL. 12, p. 3-9 7 p.

Research output: Contribution to journalReview article

37 Scopus citations

Negative symptoms in schizophrenia: a target for new drug development.

Meltzer, H. Y. & Zureick, J., Dec 1 1989, In : Psychopharmacology series. 7, p. 68-77 10 p.

Research output: Contribution to journalReview article

20 Scopus citations

Neurocognitive assessment in the clinical antipsychotic trials of intervention effectiveness (CATIE) project schizophrenia trial: Development, methodology, and rationale

Keefe, R. S. E., Mohs, R. C., Bilder, R. M., Harvey, P. D., Green, M. F., Meltzer, H. Y., Gold, J. M. & Sano, M., Jan 1 2003, In : Schizophrenia bulletin. 29, 1, p. 45-55 11 p.

Research output: Contribution to journalReview article

91 Scopus citations

Neuroleptic withdrawal in schizophrenic patients: A review of the literature

Gilbert, P. L., Harris, M. J., McAdams, L. A., Jeste, D. V., Baldessarini, R. J., Viguera, A. C., Carpenter, W. T., Tamminga, C. A., Greden, J. F., Tandon, R., Meltzer, H. Y., Nuechterlein, K. H., Gitlin, M. J., Subotnik, K. L. & Wyatt, R. J., Jan 1 1995, In : Archives of general psychiatry. 52, 3, p. 173-212 40 p.

Research output: Contribution to journalReview article

396 Scopus citations

Neuromuscular dysfunction in schizophrenia

Meltzer, H. Y., Jan 1 1976, In : Schizophrenia bulletin. 2, 1, p. 106-135 30 p.

Research output: Contribution to journalReview article

53 Scopus citations

New drugs for the treatment of schizophrenia

Meltzer, H. Y., Jan 1 1993, In : Psychiatric Clinics of North America. 16, 2, p. 365-385 21 p.

Research output: Contribution to journalReview article

74 Scopus citations

New trends in the treatment of schizophrenia

Meltzer, H. Y., Oct 1 2017, In : CNS and Neurological Disorders - Drug Targets. 16, 8, p. 900-906 7 p.

Research output: Contribution to journalReview article

13 Scopus citations

NK3 receptor antagonists for the treatment of schizophrenia

Meltzer, H. & Prus, A., Jun 1 2006, In : Drug Discovery Today: Therapeutic Strategies. 3, 4, p. 555-560 6 p.

Research output: Contribution to journalReview article

28 Scopus citations

Pathway-based analysis of GWAS datasets: Effective but caution required

Jia, P., Wang, L., Meltzer, H. Y. & Zhao, Z., May 1 2011, In : International Journal of Neuropsychopharmacology. 14, 4, p. 567-572 6 p.

Research output: Contribution to journalReview article

47 Scopus citations

Pharmacoeconomic factors related to the treatment of schizophrenia

Meltzer, H., Awad, A. G., Manning W.G., J., Shon, S. P., Diamond, R., Mahmoud, R. & Weisburd, D. E., Mar 10 1999, In : Journal of Clinical Psychiatry. 60, SUPPL. 3, p. 59-60 2 p.

Research output: Contribution to journalReview article

Pharmacogenetics of antipsychotic treatment: Lessons learned from clozapine

Masellis, M., Basile, V. S., Özdemir, V., Meltzer, H. Y., Macciardi, F. M. & Kennedy, J. L., Feb 1 2000, In : Biological psychiatry. 47, 3, p. 252-266 15 p.

Research output: Contribution to journalReview article

78 Scopus citations

Pharmacotherapy of cognition in schizophrenia

Meltzer, H. Y., Aug 1 2015, In : Current Opinion in Behavioral Sciences. 4, p. 115-121 7 p.

Research output: Contribution to journalReview article

19 Scopus citations

Platelet MAO activity in hallucinating and paranoid schizophrenics: A review and meta-analysis

Zureick, J. L. & Meltzer, H. Y., May 1988, In : Biological psychiatry. 24, 1, p. 63-78 16 p.

Research output: Contribution to journalReview article

29 Scopus citations

Practice guideline for the treatment of patients with schizophrenia

Herz, M. I., Liberman, R. P., McGlashan, T. H., Lieberman, J. A., Wyatt, R. J., Marder, S. R., Wang, P., Allgulander, C., Baldessarini, R. J., Balon, R., Bellack, A. S., Berlin, J., Blackington, C. H., Buckley, P., Carlson, D. G., Cott, J., Cournos, F., Desai, P., Dickstein, L., Fenton, W. S. & 78 others, Fisher, W. A., Flaherty, L. T., Freedman, R., Galanter, M., Galton, E., Ganguli, R., Garrettson, L. K., Goldfinger, S., Goldman, L. S., Goldstein, M. Z., Gordy, T. R., Gray, S. H., Green, M. R., Greenberg, W. M., Gunderson, J. G., Hall, L. L., Haller, E., Hanin, E., Hawkins, L., Hester, T. W., Horn, T., Hsiao, J. K., Juthani, N. V., Kane, J. M., Kayser, A., Kibel, H. D., Kimmich, R. A., Koegler, R. R., Krajeski, J., Kuehnel, T., Lamberti, J. S., Lehman, A., Leunello, J., Martin, R. L., McCarley, R., McGee, M., Meltzer, H. Y., Mesulam, M., Metzner, J. L., Mosher, L. R., Motto, J. A., Mueser, K. T., Munoz, R. A., Nasrallah, H. A., Newcomer, J. W., Opler, L. A., Peterson, G. N., Rapaport, M., Riba, M., Rickert, V. I., Rifkin, A., Rivenbark, J. S., Robertson, S., Ruiz, P., Ryan, W. G., Sanderson, M. O., Schiffer, R. B., Schyve, P. M., Sebring, R. H., Shen, W. W., Shore, D., Simpson, G. M., Soufi, H. E., Stein, L. I., Stotland, N., Strauss, J., Sundberg, D., Svendsen, D., Tohen, M., Tsuang, M., Wagnitz, J. G., Weiner, R., Weitzel, W. D., Wilkerson, L. J., Wingerson, D., Zarate, J., Zito, J. & Zonana, H. V., Jan 1 1997, In : American Journal of Psychiatry. 154, 4 SUPPL., p. 1-63 63 p.

Research output: Contribution to journalReview article

692 Scopus citations

Pre-clinical pharmacology of atypical antipsychotic drugs: A selective review

Meltzer, H. Y., Jan 1 1996, In : British Journal of Psychiatry. 168, MAY SUPPL. 29, p. 23-31 9 p.

Research output: Contribution to journalReview article

68 Scopus citations

Psychological and behavioural effects of interferons

Bonaccorso, S., Meltzer, H. & Maes, M., Nov 25 2000, In : Current opinion in psychiatry. 13, 6, p. 673-677 5 p.

Research output: Contribution to journalReview article

37 Scopus citations

Psychosis of Parkinson's disease: Serotonin 2A receptor inverse agonists as potential therapeutics

Weiner, D. M., Vanover, K. E., Brann, M. R., Meltzer, H. Y. & Davis, R. E., Jul 1 2003, In : Current Opinion in Investigational Drugs. 4, 7, p. 815-819 5 p.

Research output: Contribution to journalReview article

17 Scopus citations

Putting metabolic side effects into perspective: Risks versus benefits of atypical antipsychotics

Meltzer, H. Y., Dec 1 2001, In : Journal of Clinical Psychiatry. 62, SUPPL. 27, p. 35-39 5 p.

Research output: Contribution to journalReview article

44 Scopus citations